Clinical Outcomes in Patients with Renal Cell Carcinoma Metastases to the Choroid Plexus

被引:8
|
作者
Crisman, Celina M. [1 ]
Patel, Ankur R. [2 ,3 ]
Winston, Graham [4 ]
Brennan, Cameron W. [2 ,3 ]
Tabar, Viviane [2 ,3 ]
Moss, Nelson S. [2 ,3 ]
机构
[1] UMass Mem Med Ctr, Dept Neurosurg, Worcester, MA USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Brain Metastasis Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, New York, NY USA
基金
美国国家卫生研究院;
关键词
Choroid plexus; Intraventricular metastasis; Renal cell carcinoma; Stereotactic body radiotherapy; Stereotactic radiosurgery; BRAIN METASTASES; PROGNOSTIC-FACTORS; SURVIVAL; RADIOSURGERY; THERAPY;
D O I
10.1016/j.wneu.2020.03.125
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Intraventricular metastatic brain tumors account for a small, but challenging, fraction of metastatic brain tumors (0.9%-4.5%). Metastases from renal cell carcinoma (RCC) account for a large portion of these intraventricular tumors. Although patient outcomes have been assumed to be poor, these have not been reported in a modern series with a multimodality treatment paradigm of radiotherapy (RT), resection, and cerebrospinal fluid (CSF) diversion. We have presented the first case series of patients with intraventricular metastatic tumors from RCC. METHODS: We performed a single-institution retrospective review of patients with intraventricular RCC metastases treated from January 2003 to January 2019. Volumetric analysis was used to delineate the tumor size and the Kaplan-Meier method to evaluate the survival data. RESULTS: A total of 22 intraventricular RCC metastases were identified in 19 patients with 61.3 patient-years of follow-up. The median patient age was 64 years, and the median tumor volume was 2.2 cm(3). Overall, 19 metastases had been treated initially with RT. Of these, 16 had received stereotactic body RT and 3 had received whole brain RT. Three tumors were surgically excised and had received adjuvant stereotactic body RT in the upfront setting. Although 5 patients had presented with obstructive hydrocephalus, none had required CSF diversion. After treatment, 5 metastases had progressed, resulting in 1- and 3-year progression-free survival rates of 81.6% and 68%, respectively. The median overall survival was 2.8 years, with 1- and 5-year overall survival rates of 76.7% and 28.3%, respectively. Leptomeningeal carcinomatosis was not observed. CONCLUSIONS: Despite the relatively limited overall survival for this population with metastatic cancer, comparable to contemporary parenchymal brain metastasis cohorts, reasonable local central nervous system control was achieved in most patients using a paradigm of focal RT and resection, where indicated. Finally, CSF diversion was not required even in patients presenting with hydrocephalus.
引用
收藏
页码:E7 / E13
页数:7
相关论文
共 50 条
  • [21] Clinical Outcome of Stereotactic Radiosurgery for Central Nervous System Metastases From Renal Cell Carcinoma
    Seastone, D. J.
    Elson, P.
    Garcia, J. A.
    Chao, S. T.
    Suh, J. H.
    Angelov, L.
    Rini, B. I.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (02) : 111 - 116
  • [22] 68Ga-FAPI-04 PET/CT in Solitary Choroid Plexus Metastasis From Renal Cell Carcinoma
    Yang, Jian
    Dong, Aisheng
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (10) : 885 - 887
  • [23] Surgery Outcomes for Pulmonary Metastases from Renal Cell Carcinoma
    Choshi, Haruki
    Watanabe, Mototsugu
    Furukawa, Shinichi
    Ujike, Hiroyuki
    Kataoka, Kazuhiko
    ACTA MEDICA OKAYAMA, 2022, 76 (05) : 585 - 591
  • [24] Clinical outcomes and prognostic factors following the surgical resection of renal cell carcinoma spinal metastases
    Kato, Satoshi
    Demura, Satoru
    Murakami, Hideki
    Yoshioka, Katsuhito
    Shinmura, Kazuya
    Yokogawa, Noriaki
    Shimizu, Takaki
    Kawahara, Norio
    Tsuchiya, Hiroyuki
    CANCER SCIENCE, 2021, 112 (06) : 2416 - 2425
  • [25] Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma
    Parmar, Ambica
    Ghosh, Sunita
    Sahgal, Arjun
    Lalani, Aly-Khan A.
    Hansen, Aaron R.
    Reaume, M. Neil
    Wood, Lori
    Basappa, Naveen S.
    Heng, Daniel Y. C.
    Graham, Jeffrey
    Kollmannsberger, Christian
    Soulieres, Denis
    Breau, Rodney H.
    Tanguay, Simon
    Kapoor, Anil
    Pouliot, Frederic
    Bjarnason, Georg A.
    CANCER REPORTS, 2023, 6 (03)
  • [26] Hurthle cell carcinoma presenting as a single choroid plexus metastasis
    Healy, Andrew T.
    Otvos, Balint
    Schroeder, Jason
    Hamrahian, Amir H.
    Angelov, Lilyana
    Kamian, Kambiz
    JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (08) : 1448 - 1450
  • [27] Incidence of brain metastases in renal cell carcinoma treated with sorafenib
    Massard, C.
    Zonierek, J.
    Gross-Goupil, M.
    Fizazi, K.
    Szczylik, C.
    Escudier, B.
    ANNALS OF ONCOLOGY, 2010, 21 (05) : 1027 - 1031
  • [28] Solitary metastasis of renal cell carcinoma to the third ventricular choroid plexus with rapid clinical manifestation by intratumoral hemorrhage
    Tomiyama, Arata
    Nakayama, Haruo
    Aoki, Kazuya
    Ueda, Morikazu
    NEUROLOGY INDIA, 2008, 56 (02) : 179 - 181
  • [29] Impact of Stereotactic Radiosurgery Dose on Control of Cerebral Metastases from Renal Cell Carcinoma
    Rades, Dirk
    Huttenlocher, Stefan
    Gebauer, Niklas
    Hornung, Dagmar
    Ngo Thuy Trang
    Mai Trong Khoa
    Schild, Steven E.
    ANTICANCER RESEARCH, 2015, 35 (06) : 3571 - 3574
  • [30] THE IMPACT OF RADIOTHERAPY FIELDS IN THE TREATMENT OF PATIENTS WITH CHOROID PLEXUS CARCINOMA
    Mazloom, Ali
    Wolff, Johannes E.
    Paulino, Arnold C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 79 - 84